BioSpace News Archive

Progressive Care Inc., a personalized healthcare services and technology company, is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Tuesday, March 31st, 2020.

The Directors and Management of Immuron wish to provide an update to the market regarding the current and future impact of COVID-19 on the Company. The World is in the midst of an unprecedented health crisis as a result of the COVID-19 pandemic. An entirely new political, social, and economic reality has emerged and will continue to evolve. The consequences of this altered reality will have serious ramifications for many companies and

Real-time access to patient data can help providers address issues proactively. Medicare, Medicaid and many private insurance plans, covers services

On track to report topline data for KALM-2 Phase 3 global trial of KORSUVA™ Injection in second quarter

Drs. Mika Niemelä and Behnam Rezai Jahromi will lead efforts that initially focus on treatment of Intraventricular Hemorrhage

CPhI China launched the PharmaExcipients China in 2013, which has grown rapidly into a one-stop high-end trade exchange platform. The exhibition will be hosted at the Shanghai New International Expo Centre (SNIEC) from June 22-24, 2020

Nu-Med Plus, Inc . today announced that the Company is closely monitoring two new clinical trials that are testing Nitric Oxide Gas Inhalation Therapy for the treatment of mild/moderate COVID-19. The two new human Phase 2 clinical trials were announced at the beginning of March 2020 and are a collaborati

Surgical decision-making document contains recommendations for cancer operations and various other surgical specialty procedures

Closed $1.8 million of financing in a Private Placement on March 5, 2020 Company to Hold Conference Call on Wednesday, March 25, 2020, at 11am ET Conference Call Dial In: 877-407-9120 from the U.S.; international callers may telephone 412-902-1009 approximately 15 minutes before the call. [25-March-2020] CEDAR KNOLLS, N.J. , March 25, 2020 /PRNewsw

Microbix Biosystems Inc., a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices that help ensure test accuracy, provides an update about its Annual General Meeting.